FDA approves handheld device to assess traumatic brain injury

The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.

Advertisement

The device’s electroencephalography technology uses algorithms and machine learning to analyze patient data in various clinically relevant measures. The device then produces a digital report of the patient’s results to help clinicians assess the injury.

BrainScope, based in Bethesda, Md., developed the device, which it hopes to launch in the coming months.

More articles on supply chain:

UPS testing drones for emergency medical supply deliveries
Intermountain Healthcare recognizes 4 suppliers for outstanding work
Mylan working on EpiPen formulation with longer shelf life

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.